À retenir
In 887 community-dwelling adults aged 50 or older, sit-to-stand scores tracked gait speed, endurance and balance far more closely than grip strength, and did not track muscle mass. Confirmed sarcopenia was less common when defined by sit-to-stand (4.6% and 4.1%) than by grip strength (7.1%), a cross-sectional comparison that cannot say which definition predicts outcomes better.
Study design
Étude transversale
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia, the age-related loss of muscle, is often screened with a sit-to-stand test as a stand-in for strength or physical performance. The authors asked how two common versions, the Five Times Sit-to-Stand Test and the 30 s Chair Stand Test, relate to grip strength, muscle mass and other fitness tests, and how they change sarcopenia prevalence.
Population et méthode
Cross-sectional analysis of 887 community-dwelling adults aged 50 or older (mean age 67.3 ± 7 years, 72.9% women). Participants did the Five Times Sit-to-Stand Test (5TSTS), 30 s Chair Stand Test (30CST), grip strength, gait speed, Timed-Up-and-Go (dynamic balance) and six-minute walk test (endurance). Muscle mass was measured by multi-frequency segmental bioelectrical impedance analysis. The authors ran correlations, then multiple linear regression for independent determinants of sit-to-stand performance.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Sit-to-stand correlated weakly with grip strength (30CST r = 0.290; 5TSTS r = -0.242; both p < 0.01) and more strongly with gait speed (r = 0.517 and -0.533), endurance (r = 0.558 and -0.531) and dynamic balance (r = -0.501 and 0.646), all p < 0.01.
- 2Muscle mass correlated with grip strength but not with sit-to-stand, and sit-to-stand performance stayed independent of muscle mass in regression; all fitness measures were independently associated with 30CST.
- 3Possible sarcopenia prevalence did not differ significantly between tests (30CST 25.0%, 5TSTS 22.1%, grip strength 22.3%; p = 0.276), but using both measures raised it to 42.0%.
- 4Confirmed sarcopenia, which adds muscle mass, was lower with sit-to-stand (30CST 4.6%, 5TSTS 4.1%) than with grip strength (7.1%; p < 0.05).
Limites et incertitude
- 1Cross-sectional data cannot show whether either test better predicts falls, disability or other outcomes.
- 2The sample was 72.9% female and community-dwelling, so findings may not apply to men or to frailer older adults.
- 3Muscle mass came from bioelectrical impedance, which is less accurate than imaging methods, so the lack of link to sit-to-stand may partly reflect measurement noise.
- 4This reading is based on the abstract only.
Mise en perspective
A chair-stand score is best seen as a snapshot of overall lower-body function and balance, not of muscle size or pure strength. Different screening tests flag different people, so a result on one test should not be read as a sarcopenia diagnosis; that decision belongs with a clinician.
Vos données
You can repeat a 30-second chair stand at home under the same conditions (same chair, same time of day) and compare it with your own earlier results. Wearables do not measure this directly, but daily step count and walking speed trends reflect similar physical performance.
Comprendre ce type de preuve
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
The sit-to-stand (STS) test has been deployed as surrogate measures of strength or physical performance in sarcopenia diagnosis. This study examines the relationship of two common STS variants - Five Times Sit-to-Stand Test (5TSTS) and 30 s Chair Stand Test (30CST) - with grip strength, muscle mass and functional measures, and their impact on sarcopenia prevalence in community-dwelling older adults.
Methods
This is a cross-sectional analysis of 887 community-dwelling adults aged ≥50 years. Participants completed a battery of physical fitness tests - 5TSTS, 30CST, grip strength, gait speed, Timed-Up-and-Go (TUG) for dynamic balance and six-minute walk test (6MWT) for cardiorespiratory endurance. Muscle mass was measured using multi-frequency segmental bioelectrical impedance analysis (BIA). We performed correlation analysis between STS performance and other fitness measures and muscle mass, followed by multiple linear regression for the independent determinants of STS performance.
Results
Mean participant age was 67.3±7 years, with female predominance (72.9%). STS tests exhibited weak correlations with grip strength (30CST, r = 0.290; 5TSTS, r = - 0.242; both p< 0.01), and stronger correlations with gait speed (30CST, r = 0.517; 5TSTS, r = - 0.533; both p< 0.01), endurance (30CST, r = 0.558; 5TSTS, r = - 0.531; both p < 0.01) and dynamic balance (30CST, r = - 0.501; 5TSTS, r = 0.646; both p< 0.01). Muscle mass correlated with grip strength but not STS. In multiple regression analysis, all fitness measures were independently associated with 30CST performance. Performance in both STS tests remained independent of muscle mass. There was no significant difference in prevalence of possible sarcopenia diagnosis using grip strength or STS (30CST, 25.0%; 5TSTS, 22.1%; grip strength, 22.3%; p = 0.276). When both measures are used, prevalence is significantly higher (42.0%; p = 0.276). Prevalence of confirmed sarcopenia with inclusion of muscle mass was significantly lower using STS compared with grip strength (30CST, 4.6%; 5TSTS, 4.1% vs. grip strength, 7.1%; p< 0.05).
Conclusion
In the sarcopenia construct, STS tests better represents muscle physical performance rather than muscle strength. Different subsets of population with possible sarcopenia are identified depending on the test used. The lack of association of STS performance with muscle mass results in a lower prevalence of confirmed sarcopenia compared with grip strength, but may better reflect changes in muscle quality.
Sources et attribution
Performance on sit-to-stand tests in relation to measures of functional fitness and sarcopenia diagnosis in community-dwelling older adults.
Yee XS, Ng YS, Allen JC, Latib A, Tay EL, Abu Bakar HM, Ho CYJ, Koh WCC, Kwek HHT, Tay L.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2021-01-08
DOI: 10.1186/s11556-020-00255-5 ↗PubMed · 33419399 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

